Back to VA VANGUARD CAPITAL MANAGEMENT LLC
ELVN2 quarters
Position history for VAVANGUARD CAPITAL MANAGEMENT LLC's holdings in ENLIVEN THERAPEUTICS INC
Yes. Vanguard Capital Management holds 2,569,002 shares of ELVN (Enliven Therapeutics), worth $130.4M, as of its Q2 2026 13F filing. It increased the position by 400,840 shares (+18.5%) from Q1 2026. Vanguard Capital Management has held ELVN in every 13F on record since Q1 2026, 2 quarterly filings.
Current Value
$130.4M
Current Shares
2.6M
Total Value Change
+$45.4M
Total Shares Change
+400,840
Quarter-by-Quarter History
Other major holders of ELVN: FMR LLC, Polar Capital Holdings Plc, BlackRock, Inc.